Amneal Completes Kashiv BioSciences Acquisition to Strengthen Biosimilars Business
Amneal has completed its acquisition of Kashiv BioSciences, creating an integrated global biosimilar platform spanning R&D, manufacturing and commercialisation.
Global Biosimilars | 11/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy